Health Care: Drugs

Merck & Co Inc (MRK: NYSE)

$57.48 -0.86 | -1.47%
03/31/15 - 04:02 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 42.24B 44.03B 47.27B 48.05B
Cost of Sales 10.08B 9.97B 9.47B 9.44B
Gross Operating Profit 32.16B 34.07B 37.80B 38.60B
Selling, General, and Administrative Expenses 11.61B 11.91B 12.78B 13.73B
Research & Development 7.18B 7.50B 8.17B 8.47B
Operating Income before D & A (EBITDA) 13.37B 14.65B 16.86B 16.40B
Depreciation & Amortization 6.69B 6.99B 6.98B 7.43B
Interest Income 266.00M 264.00M 232.00M 199.00M
Other Income - Net 11.82B -278.00M -634.00M -396.00M
Special Income / Charges 0.00 404.00M 642.00M 0.00
Total Income Before Interest Expenses (EBIT) 18.02B 6.35B 9.45B 8.08B
Interest Expense 732.00M 801.00M 714.00M 749.00M
Pre-Tax Income 17.28B 5.54B 8.74B 7.33B
Income Taxes 5.35B 1.03B 2.44B 942.00M
Minority Interest 14.00M 113.00M 131.00M 120.00M
Net Income From Continuing Operations 11.93B 4.52B 6.30B 6.39B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 11.93B 4.52B 6.30B 6.39B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 11.92B 4.40B 6.17B 6.27B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
12.95B 5.82B 6.32B 7.70B
Preferred Dividends
Net Income Available To Common 11.93B 4.52B 6.30B 6.38B
Basic EPS from Continuing Ops. 4.12 1.49 2.03 2.04
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 4.12 1.49 2.03 2.04
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 4.12 1.49 2.03 2.04
Basic Normalized Net Income/Share 4.47 1.92 2.03 2.45
EPS fr Continuing Ops. 4.07 1.47 2.00 2.02
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 4.07 1.47 2.00 2.02
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 4.07 1.47 2.00 2.02
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
4.42 1.89 2.01 2.44
Dividends Paid per Share 1.77 1.73 1.69 1.56

Portfolios with MRK

Latest MRK Headlines from TheStreet

More Financial News for MRK

Press Releases for MRK

See All Press Releases

Partner Headlines for MRK

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter